Sustained Bronchodilation with Isoproterenol Poly(Glycolide-co-Lactide) Microspheres

作者: Yih-Loong Lai , Rahul C Mehta , Arthur A Thacker , Sun-Dong Yoo , Patrick J McNamara

DOI: 10.1023/A:1018989400517

关键词:

摘要: An animal study was carried out to evaluate the in vivo bronchodilator action of isoproterenol (Iso) from poly(glycolide-co-lactide) (PGL) microspheres. Microspheres with a mean diameter 4.5 µm and drug load 7% were administered intratracheally Long-Evans rats. The microspheres released about 70% incorporated instillation medium before administration, which provided immediate action, remaining 30% available for sustained release. A total 120 animals anesthetized, paralyzed, artificially ventilated, divided into 15 groups (n = 8): 3 each saline, blank microspheres, free Iso, microencapsulated Iso. All instillations made volume 1 ml/kg dose all Iso preparations 0.1 mg/kg. At 3, 6, or 12 hr after intratracheal instillation, serotonin challenge (40 µg/rat) intravenously constrict airways. Airway function tests performed at time interval on one group by maximal expiratory flow-volume maneuver. heart rate receiving formulations similar that saline control group, indicating minimal systemic effect administered. serum levels below 2 ng/ml groups. Animals encapsulated resisted least still present over this period time. On other hand, serotonin-induced airway constriction observed controls points. results clearly show only small fraction is required sustained-release form prolonged pharmacological effect, resulting 50- 100-fold reduction

参考文章(17)
Gonda I, Aerosols for delivery of therapeutic and diagnostic agents to the respiratory tract. Critical Reviews in Therapeutic Drug Carrier Systems. ,vol. 6, pp. 273- 313 ,(1990)
Toyomi Sato, Motoko Kanke, Hans G Schroeder, Patrick P DeLuca, None, Porous biodegradable microspheres for controlled drug delivery. I. Assessment of processing conditions and solvent removal techniques. Pharmaceutical Research. ,vol. 5, pp. 21- 30 ,(1988) , 10.1023/A:1015855210319
Lilon Bandler, P. Rozea, Sandra D. Anderson, J. P. Seale, Gayle Theobald, D. A. Lindsay, Inhaled and Oral Salbutamol in Exercise-Induced Asthma1, 2 The American review of respiratory disease. ,vol. 114, pp. 493- 500 ,(1976) , 10.1164/ARRD.1976.114.3.493
R. GRYGLEWSKI, J. R. VANE, The inactivation of noradrenaline and isoprenaline in dogs. British Journal of Pharmacology. ,vol. 39, pp. 573- 584 ,(1970) , 10.1111/J.1476-5381.1970.TB10365.X
Akane Mitsui, Hitoshi Nohta, Yosuke Ohkura, High-performance liquid chromatography of plasma catecholamines using 1,2-diphenylethylenediamine as precolumn fluorescence derivatization reagent Journal of Chromatography B: Biomedical Sciences and Applications. ,vol. 344, pp. 61- 70 ,(1985) , 10.1016/S0378-4347(00)82007-1
A Neville, J B Palmer, J Gaddie, C S May, K N Palmer, L E Murchison, Metabolic effects of salbutamol: comparison of aerosol and intravenous administration. BMJ. ,vol. 1, pp. 413- 414 ,(1977) , 10.1136/BMJ.1.6058.413